Modifications

Aller à la navigation Aller à la recherche
97 octets ajoutés ,  26 juillet 2019 à 12:54
aucun résumé des modifications
Ligne 89 : Ligne 89 :     
On peut constater que l'Autism Treatment Plus utilise en 2013 ce produit illicite et dangereux, voir ici<ref>http://www.autismtreatment.org.uk/2013/11/27/gcmaf-immunotherapy/ Posted by: lorene.amet@gmail.com. <br>Immunotherapy with GcMAF (Gc protein-derived macrophage activating factor)<br>Many of you would have heard of GcMAF from Dr Antonucci who presented recently at the Changing the Course of Autism Edinburgh Conference. Dr Antonucci described GcMAF as one of the most successful treatments of autism available to date. GcMAF is the equivalent of the body internal medicine.<br>What is GcMAF?<br>GcMAF presents with so much therapeutic potentials that a little explanation about what the molecule does is needed. The Vitamin D-binding receptor (VDR), a Gc-Protein, is the parent molecule of Macrophage Activating Factor termed GcMAF. GcMAF is a powerful immune activator with multiple biological effects, anti-angiogenic and anti-tumorigenic, able to enhance the body’s  immune function through the activation of macrophages, and also capable of directly acting on neurons.<br>The enzyme Nagalase (α-N-acetylgalactosaminidase) is an important player causing the deregulation of GcMAF function. Nagalase acts by deglycosylation of VDR, thus preventing it from activating macrophages and therefore suppressing the immune response. Nagalase is part of envelope of HIV and is found in cancers, viruses, and HERVs (human endogenous retroviruses). According to Professor [[Kenny de Meirleir]], Nagalase is also found associated with a range of bacterial infections, such as tick-born Borrelia, Bartonella as well as some intestinal bacteria, therefore the elevation of Nagalase does not necessarily indicates a viral infection, it can also means a bacterial infection issue. In any case, it indicates an immune deregulation and suppressed macrophage activities. [...]<br>Un des commentaires à propos de ce mail: "''is this treatment available from yourselfs ? im looking to see if this would benefit my son kyle''". Lorène Amet lui répond (December 9, 2013):
 
On peut constater que l'Autism Treatment Plus utilise en 2013 ce produit illicite et dangereux, voir ici<ref>http://www.autismtreatment.org.uk/2013/11/27/gcmaf-immunotherapy/ Posted by: lorene.amet@gmail.com. <br>Immunotherapy with GcMAF (Gc protein-derived macrophage activating factor)<br>Many of you would have heard of GcMAF from Dr Antonucci who presented recently at the Changing the Course of Autism Edinburgh Conference. Dr Antonucci described GcMAF as one of the most successful treatments of autism available to date. GcMAF is the equivalent of the body internal medicine.<br>What is GcMAF?<br>GcMAF presents with so much therapeutic potentials that a little explanation about what the molecule does is needed. The Vitamin D-binding receptor (VDR), a Gc-Protein, is the parent molecule of Macrophage Activating Factor termed GcMAF. GcMAF is a powerful immune activator with multiple biological effects, anti-angiogenic and anti-tumorigenic, able to enhance the body’s  immune function through the activation of macrophages, and also capable of directly acting on neurons.<br>The enzyme Nagalase (α-N-acetylgalactosaminidase) is an important player causing the deregulation of GcMAF function. Nagalase acts by deglycosylation of VDR, thus preventing it from activating macrophages and therefore suppressing the immune response. Nagalase is part of envelope of HIV and is found in cancers, viruses, and HERVs (human endogenous retroviruses). According to Professor [[Kenny de Meirleir]], Nagalase is also found associated with a range of bacterial infections, such as tick-born Borrelia, Bartonella as well as some intestinal bacteria, therefore the elevation of Nagalase does not necessarily indicates a viral infection, it can also means a bacterial infection issue. In any case, it indicates an immune deregulation and suppressed macrophage activities. [...]<br>Un des commentaires à propos de ce mail: "''is this treatment available from yourselfs ? im looking to see if this would benefit my son kyle''". Lorène Amet lui répond (December 9, 2013):
"''Yes it is Leeann, the first stage is to test Nagalase,which requires a blood test. You can contact me for more information, but our nurse is coming on Monday 16th.''"</ref>
+
"''Yes it is Leeann, the first stage is to test Nagalase,which requires a blood test. You can contact me for more information, but our nurse is coming on Monday 16th.''"</ref> ou <ref>http://profit-000.blogspot.com/2018/03/immunotherapy-with-gcmaf-stem-cell.html?m=0</ref>
    
== Liens externes ==
 
== Liens externes ==
12 759

modifications

Menu de navigation